Sector: MedicalMaxygen, Inc. (NASDAQ: MAXY)
Headlines
- Maxygen, Inc. Commences Dutch Auction Tender Offer to Repurchase 6,557,377 Shares of Common Stock
Nov 13, 2009 08:46 AM | MAXY
- Maxygen Reports Third Quarter 2009 Financial Results
Nov 05, 2009 04:15 PM | MAXY
- Maxygen Announces Management Changes
Sep 28, 2009 04:05 PM | MAXY
- Earnings Preview for Feb 9-13 - Earnings Preview
Feb 06, 2009 02:57 PM | ABCO, ACL, ACM, AET, AFG, AGU
- A Magic Formula Stock to Avoid: Maxygen (MAXY)
Feb 05, 2009 11:10 AM | AMGN, MAXY
- 10 Hot Stocks, One Of Which I Coulda Woulda Shoulda Bought & Banked aka Hindsight Is Easy
Dec 17, 2008 01:06 PM | ANSV, CPY, MAXY
- Earnings Preview For Nov 3 - 7 - Earnings Preview
Oct 31, 2008 10:03 PM | ABCO, ABD, ACW, ADES, AEE, AER
- Few Thoughts and a Look at the Earnings in the Coming Week
Jul 28, 2008 01:20 AM | ABCO, ACAP, ACLI, ACLS, ACXM, ADPT
- Gilead's cystic fibrosis drug meets safety goal and Polydex Reports First Quarter Financial Results
Jun 16, 2008 08:59 AM | GILD, MAXY
- Maxygen Reports Second Quarter 2009 Financial Results
Aug 06, 2009 05:51 PM | MAXY
- Maxygen Announces Second Quarter 2009 Earnings Release Date
Jul 30, 2009 08:01 PM | MAXY
- Maxygen Announces Positive Results of MAXY-G34 Phase IIa Study in Breast Cancer Patients
Jul 14, 2009 06:04 AM | MAXY
- Maxygen Announces Joint Venture With Astellas to Develop Protein Pharmaceuticals
Jun 30, 2009 07:51 PM | MAXY
- Maxygen Reports First Quarter 2009 Financial Results
May 11, 2009 05:12 PM | MAXY
- Maxygen Announces MAXY-G34 Licensing Arrangement with Cangene for Acute Radiation Syndrome
May 07, 2009 05:51 PM | MAXY
- Maxygen First Quarter 2009 Financial Results Conference Call Notice
May 07, 2009 06:13 AM | MAXY
- Vivalis : Significant Growth in Revenues and Cash Flows in Q1 2009
Apr 29, 2009 02:53 PM | MAXY, WYE
- Maxygen Reports Fourth Quarter and Year End 2008 Financial Results
Feb 10, 2009 04:04 PM | MAXY
- Maxygen Fourth Quarter and Year End 2008 Financial Results Conference Call Notice
Jan 27, 2009 06:07 AM | MAXY
- Form 4 GOLDSTEIN ELLIOT For: Oct 30 (10K)
Nov 02, 2009 09:02 PM
- Form 4 BRISCOE LAWRENCE W For: Sep 30 (10K)
Oct 02, 2009 07:18 PM
- Form 4 HOWARD RUSSELL J For: Sep 30 (10K)
Oct 02, 2009 07:17 PM
- Form 4 MARIO ERNEST For: Sep 22 (10K)
Sep 24, 2009 07:26 PM
- Form 4 RINGOLD GORDON For: Sep 22 (10K)
Sep 24, 2009 07:26 PM
- Form 4 LEE KENNETH B JR For: Sep 22 (10K)
Sep 24, 2009 07:24 PM
- Form 3 LEE KENNETH B JR For: Sep 17 (10K)
Sep 24, 2009 07:24 PM
- Form 4 LANGE LOUIS G For: Sep 22 (10K)
Sep 24, 2009 07:23 PM
- Form 4 Yonehiro Grant For: Sep 22 (10K)
Sep 24, 2009 07:22 PM
- Form 4 SULAT JAMES R For: Sep 22 (10K)
Sep 24, 2009 07:21 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MAXY
|
Compare to S&P
|
| YTD |
-37.00 %
|
-47.86 %
|
| 4 Weeks |
-2.26 %
|
-3.32 %
|
| 12 Weeks |
-17.72 %
|
-22.42 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -66.67 %
|
|
EPS Growth in Last Year: -111.68 %
|
|
Sales Growth in Last Quarter: 14.82 %
|
|
Sales Growth in Last Quarter: -91.54 %
|
|
